 |
||||
|
||||
|
||||
|
||||
The Journal of Neuroscience, July 9, 2003, 23(14):5998-6004
Previous Article | Next Article
Role of Melanocortin-4 Receptors in Mediating Renal Sympathoactivation to Leptin and Insulin
Kamal Rahmouni, William G. Haynes, Donald A. Morgan, andAllyn L. Mark Hypertension Genetics Specialized Center of Research, and Department of Internal Medicine, University of Iowa and the Veterans Administration Medical Center, Iowa City, Iowa 52242
Central melanocortin signaling plays an important role in regulation of energy homeostasis by leptin and insulin. We investigated the interaction between leptin, insulin, and melanocortin-4 receptors (MC-4Rs) in the control of renal sympathetic nerve activity (RSNA) in mice. We compared the effects of intracerebroventricular (ICV) administration of leptin, insulin, MC-3/4R agonist (MTII), and corticotrophin-releasing factor (CRF) on RSNA in leptin receptor-deficient (db/db) mice, MC-4R knock-out mice, and their wild-type controls. ICV administration of leptin and MTII caused a significant and dose-dependent increase in RSNA in control mice. As expected, leptin had no significant effect on RSNA in the db/db mice. Interestingly, db/db mice exhibited markedly attenuated RSNA responses to ICV administration of MTII. However, the increase in RSNA induced by insulin and CRF was comparable between db/db and control mice. In the heterozygous and homozygous MC-4R knock-out mice, the RSNA response to MTII was attenuated and abolished, respectively. The RSNA response to ICV leptin and insulin was also attenuated and abolished in the heterozygous and homozygous MC-4R knock-out mice, respectively. In contrast, CRF induced a similar increase in RSNA in the MC-4R knock-out and wild-type mice. Our data demonstrate that in the absence of leptin receptors, the sympathoexcitatory effects of melanocortin system stimulation are attenuated. In addition, the renal sympathoexcitatory responses to leptin and insulin are dependent on the MC-4R, demonstrating an important role for the MC-4R in the regulation of renal sympathetic nerve outflow by leptin and insulin.
Key words: obesity; melanocortin system; leptin; insulin; sympathetic nerve activity; hypothalamus
Received Feb. 12, 2003; revised May. 7, 2003; accepted May. 7, 2003.
This article has been cited by other articles:
A. A. da Silva, J. M. do Carmo, B. Kanyicska, J. Dubinion, E. Brandon, and J. E. Hall
Endogenous Melanocortin System Activity Contributes to the Elevated Arterial Pressure in Spontaneously Hypertensive Rats
Hypertension, April 1, 2008; 51(4): 884 - 890.
[Abstract] [Full Text] [PDF]
M. R. Bruchas, B. B. Land, M. Aita, M. Xu, S. K. Barot, S. Li, and C. Chavkin
Stress-Induced p38 Mitogen-Activated Protein Kinase Activation Mediates {kappa}-Opioid-Dependent Dysphoria
J. Neurosci., October 24, 2007; 27(43): 11614 - 11623.
[Abstract] [Full Text] [PDF]
K. Rahmouni and D. A. Morgan
Hypothalamic Arcuate Nucleus Mediates the Sympathetic and Arterial Pressure Responses to Leptin
Hypertension, March 1, 2007; 49(3): 647 - 652.
[Abstract] [Full Text] [PDF]
S. D. Stocker, R. Meador, and J. M. Adams
Neurons of the Rostral Ventrolateral Medulla Contribute to Obesity-Induced Hypertension in Rats
Hypertension, March 1, 2007; 49(3): 640 - 646.
[Abstract] [Full Text] [PDF]
A. A. da Silva, L. S. Tallam, J. Liu, and J. E. Hall
Chronic antidiabetic and cardiovascular actions of leptin: role of CNS and increased adrenergic activity
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1275 - R1282.
[Abstract] [Full Text] [PDF]
L. S. Tallam, A. A. da Silva, and J. E. Hall
Melanocortin-4 Receptor Mediates Chronic Cardiovascular and Metabolic Actions of Leptin
Hypertension, July 1, 2006; 48(1): 58 - 64.
[Abstract] [Full Text] [PDF]
G. M. Sutton, J. L. Trevaskis, M. W. Hulver, R. P. McMillan, N. J. Markward, M. J. Babin, E. A. Meyer, and A. A. Butler
Diet-Genotype Interactions in the Development of the Obese, Insulin-Resistant Phenotype of C57BL/6J Mice Lacking Melanocortin-3 or -4 Receptors
Endocrinology, May 1, 2006; 147(5): 2183 - 2196.
[Abstract] [Full Text] [PDF]
D. Perez-Tilve, J. E. Stern, and M. Tschop
The brain and the metabolic syndrome: not a wireless connection.
Endocrinology, March 1, 2006; 147(3): 1136 - 1139.
[Full Text] [PDF]
F. Kreier, Y. S. Kap, T. C. Mettenleiter, C. van Heijningen, J. van der Vliet, A. Kalsbeek, H. P. Sauerwein, E. Fliers, J. A. Romijn, and R. M. Buijs
Tracing from Fat Tissue, Liver, and Pancreas: A Neuroanatomical Framework for the Role of the Brain in Type 2 Diabetes
Endocrinology, March 1, 2006; 147(3): 1140 - 1147.
[Abstract] [Full Text] [PDF]
A. A. da Silva, J. J. Kuo, L. S. Tallam, J. Liu, and J. E. Hall
Does Obesity Induce Resistance to the Long-Term Cardiovascular and Metabolic Actions of Melanocortin 3/4 Receptor Activation?
Hypertension, February 1, 2006; 47(2): 259 - 264.
[Abstract] [Full Text] [PDF]
H.-R. Berthoud
First step to losing fat: central melanocortin signaling and sympathetic lipolytic drive
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1236 - R1237.
[Full Text] [PDF]
C. K. Song, R. M. Jackson, R. B. S. Harris, D. Richard, and T. J. Bartness
Melanocortin-4 receptor mRNA is expressed in sympathetic nervous system outflow neurons to white adipose tissue
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1467 - R1476.
[Abstract] [Full Text] [PDF]
Y. Zhang, G. E Kilroy, T. M. Henagan, V. Prpic-Uhing, W. G. Richards, A. W. Bannon, R. L. Mynatt, and T. W. Gettys
Targeted deletion of melanocortin receptor subtypes 3 and 4, but not CART, alters nutrient partitioning and compromises behavioral and metabolic responses to leptin
FASEB J, September 1, 2005; 19(11): 1482 - 1491.
[Abstract] [Full Text] [PDF]
L. S. Tallam, D. E. Stec, M. A. Willis, A. A. da Silva, and J. E. Hall
Melanocortin-4 Receptor-Deficient Mice Are Not Hypertensive or Salt-Sensitive Despite Obesity, Hyperinsulinemia, and Hyperleptinemia
Hypertension, August 1, 2005; 46(2): 326 - 332.
[Abstract] [Full Text] [PDF]
K. Rahmouni, M. L.G. Correia, W. G. Haynes, and A. L. Mark
Obesity-Associated Hypertension: New Insights Into Mechanisms
Hypertension, January 1, 2005; 45(1): 9 - 14.
[Abstract] [Full Text] [PDF]
L. S. Tallam, J. J. Kuo, A. A. da Silva, and J. E. Hall
Cardiovascular, Renal, and Metabolic Responses to Chronic Central Administration of Agouti-Related Peptide
Hypertension, December 1, 2004; 44(6): 853 - 858.
[Abstract] [Full Text] [PDF]
R. Gutierrez-Juarez, S. Obici, and L. Rossetti
Melanocortin-independent Effects of Leptin on Hepatic Glucose Fluxes
J. Biol. Chem., November 26, 2004; 279(48): 49704 - 49715.
[Abstract] [Full Text] [PDF]
A. A. da Silva, J. J. Kuo, and J. E. Hall
Role of Hypothalamic Melanocortin 3/4-Receptors in Mediating Chronic Cardiovascular, Renal, and Metabolic Actions of Leptin
Hypertension, June 1, 2004; 43(6): 1312 - 1317.
[Abstract] [Full Text] [PDF]
K. Rahmouni and W. G. Haynes
Leptin and the Cardiovascular System
Recent Prog. Horm. Res., January 1, 2004; 59(1): 225 - 244.
[Abstract] [Full Text]
D. C. Albarado, J. McClaine, J. M. Stephens, R. L. Mynatt, J. Ye, A. W. Bannon, W. G. Richards, and A. A. Butler
Impaired Coordination of Nutrient Intake and Substrate Oxidation in Melanocortin-4 Receptor Knockout Mice
Endocrinology, January 1, 2004; 145(1): 243 - 252.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|